Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
FS Bancorp
FSBW
$337M
| $2.96M | ﹤0.01% |
103,038
+59,615
| +137% | +$1.77M |
|
|
RAD
3277
DELISTED
Rite Aid Corporation
RAD
| $2.96M | ﹤0.01% |
438,617
-1,514,109
| -78% | -$10M |
|
|
ATRI
3278
DELISTED
Atrion Corp
ATRI
| $2.95M | ﹤0.01% |
4,694
+900
| +24% | +$588K |
|
3279
Dr. Reddy's Laboratories
RDY
$10.1B
| $2.95M | ﹤0.01% |
266,220
-3,035,750
| -92% | -$33M |
|
3280
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.67B
| $2.95M | ﹤0.01% |
32,504
-212,603
| -87% | -$20.5M |
|
3281
Upstart Holdings
UPST
$2.83B
| $2.95M | ﹤0.01% |
93,243
-79,655
| -46% | -$4.74M |
|
3282
Halozyme
HALO
$12B
| $2.95M | ﹤0.01% |
66,984
+3,746
| +6% | +$162K |
|
3283
ChargePoint
CHPT
$144M
| $2.94M | ﹤0.01% |
10,749
+5,184
| +93% | +$1.44M |
|
3284
CALL
Veru
VERU
$44.8M
| $2.94M | ﹤0.01% |
+26,000
| New | +$3.02M |
|
|
AXNX
3285
CALL
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.94M | ﹤0.01% |
+51,800
| New | +$2.84M |
|
3286
CALL
Rivian
RIVN
$23.3B
| $2.93M | ﹤0.01% |
113,800
+103,800
| +1,038% | +$3.24M |
|
3287
Vera Bradley
VRA
$94.1M
| $2.93M | ﹤0.01% |
+674,230
| New | +$4.12M |
|
3288
CALL
Arcus Biosciences
RCUS
$3.72B
| $2.92M | ﹤0.01% |
115,300
-133,700
| -54% | -$3.27M |
|
3289
SunCoke Energy
SXC
$862M
| $2.92M | ﹤0.01% |
+428,892
| New | +$3.46M |
|
|
DISH
3290
CALL
DELISTED
DISH Network Corp.
DISH
| $2.92M | ﹤0.01% |
+162,700
| New | +$3.94M |
|
3291
WSFS Financial
WSFS
$4B
| $2.92M | ﹤0.01% |
+72,727
| New | +$2.99M |
|
3292
Biomea Fusion
BMEA
$125M
| $2.91M | ﹤0.01% |
+243,124
| New | +$1.42M |
|
|
ECOM
3293
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $2.9M | ﹤0.01% |
198,794
-283,275
| -59% | -$4.05M |
|
3294
Freshworks
FRSH
$3.62B
| $2.9M | ﹤0.01% |
220,115
-8,234
| -4% | -$128K |
|
3295
BlueLinx
BXC
$624M
| $2.89M | ﹤0.01% |
43,318
-128,357
| -75% | -$9.64M |
|
3296
Amneal Pharmaceuticals
AMRX
$6.11B
| $2.89M | ﹤0.01% |
908,279
+772,235
| +568% | +$2.8M |
|
|
QFTA
3297
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
| $2.89M | ﹤0.01% |
293,584
-102,723
| -26% | -$1.01M |
|
|
KCA.U
3298
DELISTED
Kensington Capital Acquisition Corp. IV New units, each consisting of one Class A ordinary share and one Class 2 redeemable warrant
KCA.U
| $2.88M | ﹤0.01% |
+300,000
| New | +$2.91M |
|
3299
CALL
NCR Voyix
VYX
$1.21B
| $2.88M | ﹤0.01% |
+150,938
| New | +$3.22M |
|
3300
Mattel
MAT
$4.33B
| $2.87M | ﹤0.01% |
128,664
-756,085
| -85% | -$17.9M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.